*Actual product packaging may differ from the image shown.
Sermorelin (Oral Troches)
Shop All Treatments
Sermorelin Troches: Dissolving Lozenge Alternative to Injection
The same pituitary-stimulating peptide, in a sublingual troche that dissolves under your tongue.
Sermorelin troches are dissolving lozenges placed under the tongue or in the cheek pouch, where sermorelin can be absorbed across the oral mucosa. For people who would prefer not to inject, the troche offers an alternative delivery route. Bioavailability is generally lower than with subcutaneous injection, so dosing is typically higher to compensate.
Physician-prescribed · Compounded by licensed US pharmacies · Needle-free delivery · Ongoing care team support
Sermorelin (Sublingual/Buccal Delivery): Sermorelin is a synthetic analog of the first 29 amino acids of GHRH, your body’s own signal to the pituitary to release growth hormone. When taken at bedtime, it amplifies your natural overnight GH pulse, leading to a measurable rise in IGF-1. Because it works upstream of the pituitary and is subject to your body’s normal negative feedback, the risk of supraphysiologic GH levels is substantially lower than with exogenous HGH. Sublingual absorption is less complete than direct injection, and oral peptide bioavailability remains an area of active study. The troche format is best understood as a needle-free alternative for patients prioritizing convenience.
Best for: Adults over 30 who want sermorelin’s pituitary support but would strongly prefer not to inject. A reasonable fit for those willing to trade some bioavailability for needle-free delivery.
Not recommended for: Anyone with active malignancy (GH and IGF-1 can promote tumor growth), those with a known pituitary tumor, pregnant or breastfeeding individuals, and patients with severe untreated hypothyroidism.
Most common side effects are mild mouth or throat irritation, occasional headache, and vivid dreams. Systemic effects mirror sermorelin injection but are typically milder due to lower bioavailability.
¹ Raised IGF-1 by about 35% over 6 months in older adults Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. JCEM, 1997;82(5):1472-1479. → PubMed
² Increased lean body mass (about 1.3 kg in men) in a randomized trial Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 2007;146(2):104-115. → PubMed
³ A convenient needle-free format Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006;1(4):307-308. (Sermorelin efficacy data derive from subcutaneous administration; buccal/oral-strip absorption of a 29-amino-acid peptide is not characterized in published trials.) → PubMed
How it Works With EHRX
The entire process is online. No waiting rooms. Just straightforward, medically guided care.
Step 1
Choose your treatment and complete checkout
You'll receive a confirmation email with next steps.
Step 2
Complete a brief medical consultation
Check your email for a link to a short intake form and link to a virtual consult with a licensed physician.
Step 3
A licensed provider reviews your consultation
If approved, your prescription is written and sent to the pharmacy. If not, you receive a full refund.
Step 4
Your pharmacy ships within 3–5 business days
Your medication is shipped directly to your door in temperature-controlled packaging.
What to know before you start.
Sermorelin (Oral Troches) is a compounded medication prepared by a licensed pharmacy for individual patient use.
It has not been reviewed by the FDA for safety or efficacy, and is prescribed based on the clinical judgment of a qualified healthcare provider. Compounded drugs are permitted to be prescribed but are not FDA-approved for safety and efficacy.
Clinical Evidence
Sermorelin’s clinical evidence comes primarily from injectable formulations. Sublingual and buccal absorption of peptides is studied with variable results; bioavailability is generally lower than subcutaneous injection. (Source: Walker, Clinical Interventions in Aging, 2006)
Frequently Asked Questions
We aim to provide absolute clarity regarding your biological data and personalized wellness protocols.
Dissolve one troche under your tongue or in your cheek before bed. Don’t chew or swallow whole. Avoid food or drink for 15 to 30 minutes after.
Same active peptide. The troche is needle-free but has lower bioavailability, so dosing is typically adjusted.
Sleep quality may shift within 2 to 4 weeks. Body composition changes typically take 3 to 6 months with consistent training and nutrition.
No. Adult prescribing uses IGF-1 levels and clinical symptoms.
Baseline IGF-1 and a metabolic panel establish your starting point and confirm safety.
You won’t be charged for the medication.
No. Compounded peptides are paid out of pocket.
Yes, at any time before your next shipment, with no long-term commitment.
IGF-1 retest at 8 to 12 weeks, with ongoing check-ins at a recurring cadence.
Discuss with your provider. Some patients respond better to the injectable form.
The next generation
of weight management.
Dual-incretin metabolic support — personalized to you.
